{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:33Z","timestamp":1790154453910,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25,469,525"],"award-info":[{"award-number":["RS-2026-25,469,525"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-NR076471"],"award-info":[{"award-number":["RS-2023-NR076471"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-2,549,455"],"award-info":[{"award-number":["RS-2026-2,549,455"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.humimm.2026.112042","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:37:53Z","timestamp":1786725473000},"page":"112042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoinformatics-driven design of a multiepitope vaccine against the EGFR extracellular domain for head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"87","author":[{"given":"Fahad Hassan","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Sig","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Woo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rae","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jae","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Joo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.112042_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218015","article-title":"Cancer stem cell mechanisms and targeted therapeutic strategies in head and neck squamous cell carcinoma","volume":"634","author":"Maharajan","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.humimm.2026.112042_bb0010","article-title":"New advances in the therapeutic strategy of head and neck squamous cell carcinoma: a review of latest therapies and cutting-edge research","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.humimm.2026.112042_bb0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.18632\/oncotarget.28747","article-title":"Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: insights into RTK dependent and independent mechanisms","volume":"16","author":"Shyamsunder","year":"2025","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2026.112042_bb0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/jamaoncol.2025.3136","article-title":"Emerging EGFR-targeted therapy in head and neck cancer: a review","volume":"11","author":"Hwang","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.humimm.2026.112042_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102864","article-title":"Current status and future prospects of combined immunotherapy and epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma","volume":"132","author":"Tian","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.humimm.2026.112042_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-025-02290-1","article-title":"EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer","volume":"24","author":"Zhou","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.humimm.2026.112042_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217710","article-title":"Cancer-associated fibroblasts derived amphiregulin promotes HNSCC progression and drug resistance of EGFR inhibitor","volume":"622","author":"Zhou","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.humimm.2026.112042_bb0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s43440-025-00745-2","article-title":"Novel receptor tyrosine kinase-targeted strategies to overcome resistance in oral squamous cell carcinoma","volume":"77","author":"Irannejadrankouhi","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.humimm.2026.112042_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.25259\/IJMIO_40_2025","article-title":"Molecular landscape of head and neck cancers\u2013therapeutic implications","volume":"11","author":"Muddabhaktuni","year":"2026","journal-title":"Int. J. Mol. Immuno Oncol."},{"key":"10.1016\/j.humimm.2026.112042_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105207","article-title":"Beyond EGFR inhibition in head and neck squamous cell carcinoma: overcoming resistance mechanisms and novel therapeutic frontiers","volume":"221","author":"Carosi","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.humimm.2026.112042_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202505785","article-title":"EGFR: new insights on its activation and mutation in tumor and tumor immunotherapy","volume":"12","author":"Gu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.humimm.2026.112042_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-026-01744-w","article-title":"Integrative structural and dynamics studies of epidermal growth factor receptor (EGFR)","author":"Yoon","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.humimm.2026.112042_bb0065","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3390\/biom14121620","article-title":"Rational design of an epidermal growth factor receptor vaccine: immunogenicity and antitumor research","volume":"14","author":"Liu","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.humimm.2026.112042_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000488408","article-title":"The immunogenicity and anti-tumor efficacy of a rationally designed EGFR vaccine","volume":"46","author":"Cheng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.humimm.2026.112042_bb0075","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.str.2013.05.008","article-title":"Structural evaluation of EGFR inhibition mechanisms for nanobodies\/VHH domains","volume":"21","author":"Schmitz","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.humimm.2026.112042_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"10.1016\/j.humimm.2026.112042_bb0085","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.humimm.2026.112042_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.humimm.2026.112042_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108926","article-title":"ToxinPred 3.0: an improved method for predicting the toxicity of peptides","volume":"179","author":"Rathore","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.humimm.2026.112042_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12985-026-03099-0","article-title":"Computational design of a novel multi-epitope vaccine candidate against group a rotavirus","volume":"23","author":"Pajand","year":"2026","journal-title":"Virol. J."},{"key":"10.1016\/j.humimm.2026.112042_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0335147","article-title":"Rational design of multi-epitope vaccine for Chandipura virus using an immunoinformatics approach","volume":"20","author":"Naderian","year":"2025","journal-title":"PLoS ONE"},{"key":"10.1016\/j.humimm.2026.112042_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030839","article-title":"Synthetic toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants","volume":"7","author":"Shanmugam","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.humimm.2026.112042_bb0120","doi-asserted-by":"crossref","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","article-title":"The immune epitope database (IEDB): 2024 update","volume":"53","author":"Duesing","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0125","series-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.humimm.2026.112042_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bioinformatics\/btaa1102","article-title":"SoluProt: prediction of soluble protein expression in Escherichia coli","volume":"37","author":"Hon","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humimm.2026.112042_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"10.1016\/j.humimm.2026.112042_bb0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","article-title":"The PSIPRED protein structure prediction server","volume":"16","author":"McGuffin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humimm.2026.112042_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.humimm.2026.112042_bb0150","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.bpj.2011.10.024","article-title":"Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization","volume":"101","author":"Xu","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.humimm.2026.112042_bb0155","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0160","doi-asserted-by":"crossref","DOI":"10.1107\/S1600576725001669","article-title":"RamPlot: a webserver to draw 2D, 3D and assorted Ramachandran (\u03d5, \u03c8) maps","volume":"58","author":"Kumar","year":"2025","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.humimm.2026.112042_bb0165","series-title":"Methods Enzymol.","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"[20] VERIFY3D: assessment of protein models with three-dimensional profiles","author":"Eisenberg","year":"1997"},{"key":"10.1016\/j.humimm.2026.112042_bb0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humimm.2026.112042_bb0175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-14-346","article-title":"Disulfide by design 2.0: a web-based tool for disulfide engineering in proteins","volume":"14","author":"Craig","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.humimm.2026.112042_bb0180","article-title":"Immunoinformatics and molecular modeling approaches to design a multi-epitope vaccine against Tibrovirus Congo","volume":"21","author":"Naveed","year":"2026","journal-title":"Open Med."},{"key":"10.1016\/j.humimm.2026.112042_bb0185","doi-asserted-by":"crossref","first-page":"W306","DOI":"10.1093\/nar\/gkaf379","article-title":"HawkDock version 2: an updated web server to predict and analyze the structures of protein\u2013protein complexes","volume":"53","author":"Zhang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0190","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.csbj.2023.09.024","article-title":"CHAPERONg: a tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses","volume":"21","author":"Yekeen","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.humimm.2026.112042_bb0195","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0200","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0205","article-title":"Role of novel bispecific antibodies and immunotherapy in non\u2013small cell lung cancer with common epidermal growth factor receptor mutations","volume":"9","author":"Su","year":"2025","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.humimm.2026.112042_bb0210","first-page":"1196","article-title":"CP91110P: a computationally designed multi-epitope vaccine candidate for tuberculosis via TLR-2\/4 synergistic immunomodulation","volume":"14","author":"An","year":"2025","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.humimm.2026.112042_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/bta\/201461","article-title":"In silico screening and identification of CTL and HTL epitopes in the secreted virulence factors of Mycobacterium tuberculosis","volume":"106","author":"Bragais","year":"2025","journal-title":"BioTechnologia"},{"key":"10.1016\/j.humimm.2026.112042_bb0220","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129641","article-title":"Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer","volume":"4","author":"Garaud","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.humimm.2026.112042_bb0225","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/1078-0432.CCR-20-3586","article-title":"Role of tumor-infiltrating B cells in clinical outcome of patients with melanoma treated with Dabrafenib plus Trametinib","volume":"27","author":"Brase","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molimm.2020.10.014","article-title":"Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking","volume":"128","author":"Xi","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2026.112042_bb0235","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.13005\/bbra\/1917","article-title":"In silico and in vitro evaluation of a recombinant fusion peptide as a novel candidate vaccine for EGFR-positive tumors","volume":"12","author":"Asadi-Ghalehni","year":"2015","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"10.1016\/j.humimm.2026.112042_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12985-026-03072-x","article-title":"Design and computational evaluation of a prophylactic and therapeutic multi-epitope vaccine candidate against cervical cancer","volume":"23","author":"Emadi","year":"2026","journal-title":"Virol. J."},{"key":"10.1016\/j.humimm.2026.112042_bb0245","article-title":"Designing a multi-epitope vaccine against yellow fever virus using immunoinformatics approaches","volume":"21","author":"Naveed","year":"2026","journal-title":"Open Med."},{"key":"10.1016\/j.humimm.2026.112042_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s11274-026-05022-9","article-title":"Integrative 16S rRNA characterization, pan-genome, and immunoinformatics approaches for the design of a multi-epitope vaccine against Bacillus cereus, a foodborne pathogen","volume":"42","author":"Asim","year":"2026","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.humimm.2026.112042_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2026.100991","article-title":"Immunoinformatics-driven design of a multi-epitope vaccine against Seoul virus: structural, dynamic, and immunogenic profiling","volume":"81","author":"Naveed","year":"2026","journal-title":"Clinics"},{"key":"10.1016\/j.humimm.2026.112042_bb0260","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1158\/1078-0432.CCR-15-0855","article-title":"A phase III clinical trial of the epidermal growth factor vaccine CIMAvax-EGF as switch maintenance therapy in advanced non\u2013small cell lung cancer patients","volume":"22","author":"Rodriguez","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2026.112042_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1287902","article-title":"Safety and effectiveness of CIMAvax-EGF administered in community polyclinics","volume":"13","author":"Ortiz Carrodeguas","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.humimm.2026.112042_bb0270","article-title":"Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions","volume":"15","author":"Friedman","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2026.112042_bb0275","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/cncr.26574","article-title":"Clinical trial results of the HER-2\/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group study I-01 and I-02","volume":"118","author":"Mittendorf","year":"2012","journal-title":"Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926003885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926003885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:37:41Z","timestamp":1790152661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926003885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0198885926003885"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112042","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoinformatics-driven design of a multiepitope vaccine against the EGFR extracellular domain for head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"112042"}}